mayo clinic glp-1 Why do some people lose substantial weight with GLP-1-based medications while others see more modest results? A study offers a potential answer by identifying a distinct biological subtype A Mayo Clinic study found
Description
Accessed February 29, 2024
Semaglutide is a GLP-1 receptor agonist a class of medication that mimics the incretin hormone GLP-1, which plays a key role in appetite regulation, insulin secretion, and gastric emptying
Activation of GLP-1R has been associated with the induction of antioxidant enzymes, such as superoxide dismutase ( SOD ) and catalase, which are involved in the neutralization of ROS [87]
If youre not seeing results or experiencing intolerable side effects with one medication, your doctor can transition you to another
GLP-1 stands for glucagon-like peptide-1 and yes, there is more than one
That practical distinction has significant implications for real-world adherence and patient access
